INHIBITION OF TUMOR-GROWTH INDUCED BY HISTAMINE - INVIVO AND INVITRO STUDIES

被引:9
作者
CRICCO, GP [1 ]
DAVIO, CA [1 ]
BERGOC, RM [1 ]
RIVERA, ES [1 ]
机构
[1] UNIV BUENOS AIRES,FAC FARM & BIOQUIM,CATEDRA FIS,RADIOISOTOPOS LAB,JUNIN 956 PB,RA-1113 BUENOS AIRES,ARGENTINA
来源
AGENTS AND ACTIONS | 1993年 / 38卷
关键词
D O I
10.1007/BF01996451
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An experimental mammary carcinoma was induced in rats by the i.p. administration of N-nitroso N-methylurea (NMU) in 3 doses of 50 mg/kg. In order to study the role of histamine (Hi) and its receptors in tumor growth, in vivo and in vitro treatments were carried out. Different groups of animals received a daily s.c. injection of Hi 0.1 mg/kg, starting with the first dose of NMU. Hi significantly reduced tumor incidence and the number of tumors developed per rat. The in vitro studies, using the clonogenic agar technique, showed no difference in colony formation between control, 0.01 and 0.1 muM Hi treatment, while 1 and 10 muM Hi concentrations induced inhibition of cell growth up to 60 %. This effect was abolished by H-1 antagonists. Conversely, the action of the H-2 antagonists was a significant inhibition of colony formation. We may then conclude that in these experimental tumors, histamine exerts a regulatory function on cell growth by acting directly on specific membrane receptors.
引用
收藏
页码:C175 / C177
页数:3
相关论文
共 10 条
[1]  
BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55
[2]   CLINICAL IMPROVEMENT IN ADVANCED CANCER DISEASE AFTER TREATMENT COMBINING HISTAMINE AND H2-ANTIHISTAMINICS (RANITIDINE OR CIMETIDINE) [J].
BURTIN, C ;
NOIROT, C ;
SCHEINMANN, P ;
GALOPPIN, L ;
SABOLOVIC, D ;
BERNARD, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02) :161-167
[3]  
CHOCHUNG YS, 1990, CANCER RES, V50, P7093
[4]   CHANGES IN HISTAMINE SYNTHESIS, TISSUE CONTENT AND CATABOLISM IN HUMAN-BREAST CANCER [J].
GARCIACABALLERO, M ;
NEUGEBAUER, E ;
RODRIGUEZ, F ;
DECASTRO, IN ;
HEREDIA, A ;
OOSTING, E ;
THORBECK, CV .
AGENTS AND ACTIONS, 1989, 27 (1-2) :227-231
[5]  
MANNI A, 1983, CANCER RES, V43, P1081
[6]  
SCOLNIK AJ, 1986, ACTA BIOQUIM CLIN L, V20, P469
[7]  
SCOLNIK JA, 1985, TRENDS PHARMACOL SCI, V6, P357
[8]   HISTAMINE AS A GROWTH-FACTOR AND CHEMOATTRACTANT FOR HUMAN CARCINOMA AND MELANOMA-CELLS - ACTION THROUGH CA-2+-MOBILIZING H1 RECEPTORS [J].
TILLY, BC ;
TERTOOLEN, LGJ ;
REMORIE, R ;
LADOUX, A ;
VERLAAN, I ;
DELAAT, SW ;
MOOLENAAR, WH .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1211-1215
[9]   THE EFFECTS OF HISTAMINE-H2-RECEPTOR ANTAGONISTS ON MELANOGENESIS AND CELLULAR PROLIFERATION IN MELANOMA-CELLS IN CULTURE [J].
UCAR, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (01) :545-550
[10]   DEMONSTRATION OF HISTAMINE H-2 RECEPTORS ON HUMAN-MELANOMA CELLS [J].
WHITEHEAD, RJ ;
TAYLOR, DJ ;
EVANSON, JM ;
HART, IR ;
WOOLLEY, DE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (01) :518-523